Grants paid by Nf2 Biosolutions
EIN 83-0940046 · West Chester, PA · Form 990, Schedule I · NTEE G20
Nf2 Biosolutions of West Chester, PA (EIN 83-0940046) reported 26 grants paid totaling $1,675,348 to 13 recipients in tax years 2020–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$1,675,348
26 grants
Recipients
13
distinct organizations
Tax years
2020–2024
5 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2020 | 1 | $394,000 | — |
| 2021 | 5 | $241,485 | — |
| 2022 | 5 | $143,185 | — |
| 2023 | 11 | $734,156 | — |
| 2024 | 4 | $162,522 | — |
Top recipients
The 13 recipients receiving the most from Nf2 Biosolutions, by grants paid, out of 13 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Mulberry Therapeutics | U | Wellesley Hills, MA | 1 | $521,000 | 2023 |
| Laboratory of Gary Brenner Md | U | Boston, MA | 1 | $394,000 | 2020 |
| Mass Gen Development Office 04-3167352 | A | Boston, MA | 4 | $240,512 | 2024 |
| Yale University 06-0646973 | A | New Haven, CT | 4 | $158,658 | 2024 |
| Indiana University Research 35-6001673 | A | Bloomington, IN | 2 | $94,014 | 2023 |
| Research Institute at Nationwide Ch 31-6056230 | A | Columbus, OH | 2 | $61,380 | 2024 |
| Laboratory of Gary Brenner Md 04-2103580 | A | Boston, MA | 1 | $57,500 | 2021 |
| Institute for Cancer Research 23-6296135 | A | Philadelphia, PA | 2 | $37,500 | 2023 |
| Merlin Therapeutics | U | King of Prussia, PA | 2 | $35,991 | 2024 |
| William Cancer Institute Pc 85-1161231 | A | Beverly Hills, CA | 1 | $35,436 | 2023 |
| Chop Research Institute 23-2237932 | A | Philadelphia, PA | 3 | $31,707 | 2023 |
| University of California 94-3067788 | A | Los Angeles, CA | 2 | $5,812 | 2023 |
| Cell Culture Company LLC | U | Minneapolis, MN | 1 | $1,838 | 2023 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 26 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Research Institute at Nationwide Ch Columbus, OH | A | $60,380 | paid | RESEARCH | 202543219349322319 |
| 2024 | Mass Gen Development Office Boston, MA | A | $60,000 | paid | DEVELOPMENT OF BACTERIOTHERAPY FOR NF2 | 202543219349322319 |
| 2024 | Yale University New Haven, CT | A | $36,351 | paid | TUMOR IMAGING MODEL | 202543219349322319 |
| 2024 | Merlin Therapeutics King of Prussia, PA | U | $5,791 | paid | RESEARCH | 202543219349322319 |
| 2023 | Mulberry Therapeutics Wellesley Hills, MA | U | $521,000 | paid | research | 202443149349300734 |
| 2023 | Mass Gen Development Office Boston, MA | A | $60,512 | paid | development of bacteriotherapy for NF2 | 202443149349300734 |
| 2023 | Indiana University Research Bloomington, IN | A | $47,007 | paid | research | 202443149349300734 |
| 2023 | Yale University New Haven, CT | A | $36,351 | paid | tumor imaging model | 202443149349300734 |
| 2023 | William Cancer Institute Pc Beverly Hills, CA | A | $35,436 | paid | research | 202443149349300734 |
| 2023 | Merlin Therapeutics King of Prussia, PA | U | $30,200 | paid | 202443149349300734 | |
| 2023 | Cell Culture Company LLC Minneapolis, MN | U | $1,838 | paid | research | 202443149349300734 |
| 2023 | Research Institute at Nationwide Ch Columbus, OH | A | $1,000 | paid | research | 202443149349300734 |
| 2023 | University of California Los Angeles, CA | A | $812 | paid | research | 202443149349300734 |
| 2023 | Chop Research Institute Philadelphia, PA | A | $0 | paid | developing a tumor biobank for NF2 | 202443149349300734 |
| 2023 | Institute for Cancer Research Philadelphia, PA | A | $0 | paid | research | 202443149349300734 |
| 2022 | Yale University New Haven, CT | A | $72,702 | paid | tumor imaging model | 202343009349300304 |
| 2022 | Institute for Cancer Research Philadelphia, PA | A | $37,500 | paid | research | 202343009349300304 |
| 2022 | Mass Gen Development Office Boston, MA | A | $20,000 | paid | development of bacteriotherapy for NF2 | 202343009349300304 |
| 2022 | Chop Research Institute Philadelphia, PA | A | $7,983 | paid | developing a tumor biobank for NF2 | 202343009349300304 |
| 2022 | University of California Los Angeles, CA | A | $5,000 | paid | research | 202343009349300304 |
| 2021 | Mass Gen Development Office Boston, MA | A | $100,000 | paid | development of bacteriotherapy for NF2 | 202222309349300337 |
| 2021 | Laboratory of Gary Brenner Md Boston, MA | A | $57,500 | paid | development of bacteriotherapy for NF2 | 202222309349300337 |
| 2021 | Indiana University Research Bloomington, IN | A | $47,007 | paid | drug testing | 202222309349300337 |
| 2021 | Chop Research Institute Philadelphia, PA | A | $23,724 | paid | developing a tumor biobank for NF2 | 202222309349300337 |
| 2021 | Yale University New Haven, CT | A | $13,254 | paid | tumor imaging model | 202222309349300337 |
| 2020 | Laboratory of Gary Brenner Md Boston, MA | U | $394,000 | paid | therapy for NF2 | 202201379349300835 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202543219349322319 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202443149349300734 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202343009349300304 |
| 990 | 2021 | 2021-12-31 | not stated | 2021v4.2 | 202222309349300337 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202201379349300835 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/830940046.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.